Researchers in Hong Kong have found that patients experiencing milder illness caused by the novel coronavirus recover more quickly if they are treated with a three-drug antiviral cocktail soon after symptoms appear.
Authors of the study, published in The Lancet on Friday, described the findings as “early, but important.”
They called for larger-scale research on critically ill patients to ascertain if the drug combo could be a viable treatment for them, too.
“Our trial demonstrates that early treatment of mild to moderate COVID-19 with a triple combination of antiviral drugs may rapidly suppress the amount of virus in a patient’s body,” said University of Hong Kong professor of microbiology Yuen Kwok-yung (袁國勇), who led the research.
The treatment, which appeared safe in patients, was shown to “relieve symptoms, and reduce the risk to healthcare workers by reducing the duration and quantity of viral shedding (when the virus is detectable and potentially transmissible),” Yuen wrote.
Scientists are racing to identify medicines to use against COVID-19, but there is currently no treatment, cure or vaccine.
The study tracked the virus in 127 adults admitted to six hospitals in Hong Kong after they tested positive.
Of those participating, 86 were given a two-week course of three medicines: interferon beta-1b, a drug used to treat multiple sclerosis; a combination of lopinavir and ritonavir used to fight HIV; and ribavirin, used to treat hepatitis.
A randomly assigned control group of 41 people was just given the lopinavir-ritonavir combination.
Treatment began on average five days after symptoms started and all patients otherwise received standard care, including oxygen therapy.
Researchers then measured how long it took for a swab test for the virus to turn out negative. They found that those taking all three medicines were able to clear the coronavirus in seven days on average (between five and 11 days) — “significantly” shorter than the 12-day average for the control group.
Those on the three-drug regimen also saw a complete alleviation of their symptoms in an average of four days, compared with eight for the control group.
“Future clinical study of a double antiviral therapy with interferon beta-1b as a backbone is warranted,” the study said.
CRITICAL MOVE: TSMC’s plan to invest another US$100 billion in US chipmaking would boost Taiwan’s competitive edge in the global market, the premier said The government would ensure that the most advanced chipmaking technology stays in Taiwan while assisting Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) in investing overseas, the Presidential Office said yesterday. The statement follows a joint announcement by the world’s largest contract chipmaker and US President Donald Trump on Monday that TSMC would invest an additional US$100 billion over the next four years to expand its semiconductor manufacturing operations in the US, which would include construction of three new chip fabrication plants, two advanced packaging facilities, and a research and development center. The government knew about the deal in advance and would assist, Presidential
‘DANGEROUS GAME’: Legislative Yuan budget cuts have already become a point of discussion for Democrats and Republicans in Washington, Elbridge Colby said Taiwan’s fall to China “would be a disaster for American interests” and Taipei must raise defense spending to deter Beijing, US President Donald Trump’s pick to lead Pentagon policy, Elbridge Colby, said on Tuesday during his US Senate confirmation hearing. The nominee for US undersecretary of defense for policy told the Armed Services Committee that Washington needs to motivate Taiwan to avoid a conflict with China and that he is “profoundly disturbed” about its perceived reluctance to raise defense spending closer to 10 percent of GDP. Colby, a China hawk who also served in the Pentagon in Trump’s first team,
SEPARATE: The MAC rebutted Beijing’s claim that Taiwan is China’s province, asserting that UN Resolution 2758 neither mentions Taiwan nor grants the PRC authority over it The “status quo” of democratic Taiwan and autocratic China not belonging to each other has long been recognized by the international community, the Mainland Affairs Council (MAC) said yesterday in its rebuttal of Beijing’s claim that Taiwan can only be represented in the UN as “Taiwan, Province of China.” Chinese Minister of Foreign Affairs Wang Yi (王毅) yesterday at a news conference of the third session at the 14th National People’s Congress said that Taiwan can only be referred to as “Taiwan, Province of China” at the UN. Taiwan is an inseparable part of Chinese territory, which is not only history but
INVESTMENT WATCH: The US activity would not affect the firm’s investment in Taiwan, where 11 production lines would likely be completed this year, C.C. Wei said Investments by Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) in the US should not be a cause for concern, but rather seen as the moment that the company and Taiwan stepped into the global spotlight, President William Lai (賴清德) told a news conference at the Presidential Office in Taipei yesterday alongside TSMC chairman and chief executive officer C.C. Wei (魏哲家). Wei and US President Donald Trump in Washington on Monday announced plans to invest US$100 billion in the US to build three advanced foundries, two packaging plants, and a research and development center, after Trump threatened to slap tariffs on chips made
RSS